Diagnostic performance of circulating microRNA signatures for differentiating tuberculosis disease from tuberculosis infection
Authors:
- Anne Ahrens ØstergaardAØAnne Ahrens Østergaard
- Stephanie BjerrumSBStephanie Bjerrum
- Kristian AssingKAKristian Assing
- Maria Bisgaard BorupMBMaria Bisgaard Borup
- Rasmus Bank LynggaardRLRasmus Bank Lynggaard
- Christiane AbildgaardCAChristiane Abildgaard
- Ingrid Louise TitlestadITIngrid Louise Titlestad
- Torben Tranborg JensenTJTorben Tranborg Jensen
- Hans Johan Niklas LorentssonHLHans Johan Niklas Lorentsson
- Ole HilbergOHOle Hilberg
- Christian Morberg WejseCWChristian Morberg Wejse
- Søren FeddersenSFSøren Feddersen
Open Access
- 24 September 2025
- journal article
- research article
- Published by Springer Nature in Medical Microbiology and Immunology
- Vol. 214 (1) , 1-18
Abstract
As regulators of innate and adaptive immunity, microRNAs (miRNAs) could aid in the discrimination between tuberculosis disease (TB) and (latent) TB infection (TBI). We analysed 754 circulating miRNAs in participants diagnosed with TB and TBI using TaqMan™ Advanced miRNA Human A and B cards. MiRNAs were normalized exogenously and endogenously via geometric means of selected reference miRNAs. Expression analysis was used to identify miRNAs that were significantly differentially expressed between individuals with TB and those with TBI. We utilised recursive feature elimination with a Random Forest model to identify the miRNAs most effective at discriminating TB from TBI and subsequently validated the miRNA in another group. 95 persons diagnosed with TB or TBI was divided into a discovery group (n = 36) and a validation group (n = 59). In the discovery group, we identified 495 distinct miRNAs in 36 persons with TB or TBI and by recursive feature elimination identified hsa-miR-148a-3p, hsa-miR-204-5p and hsa-miR-584-5p and created a three-miRNA-diagnostic model. In the validation group, the three-miRNA-diagnostic model had poorer performance. Expression analysis revealed 13 significantly differentially expressed miRNAs, including hsa-miR-148a-3p and hsa-miR-204-5p. Subsequent analysis in a validation group consisting of 59 persons revealed that six of the 14 miRNAs, including hsa-miR-148a-3p, exhibited the same pattern, albeit without statistical significance. Three circulating miRNAs showed potential for differentiating TB from TBI in the discovery cohort, but these differences were less pronounced in the validation cohort.Keywords
Funding Information
- University of Southern Denmark
This publication has 51 references indexed in Scilit:
- Influence of sex and liver cirrhosis on the expression of miR-146a-5p and its target genes, IRAK1 and TRAF6Brain Research, 2024
- Role of microRNA-146a in cancer development by regulating apoptosisPathology - Research and Practice, 2023
- Integrating serum microRNAs and electronic health records improved the diagnosis of tuberculosisJournal of Clinical Laboratory Analysis, 2021
- High sensitivity and specificity of a 5‐analyte protein and microRNA biosignature for identification of active tuberculosisClinical & Translational Immunology, 2021
- Down-Regulation of Circular RNA_000926 Attenuates Renal Cell Carcinoma Progression through miRNA-411–Dependent CDH2 InhibitionThe American Journal of Pathology, 2019
- Host and MTB genome encoded miRNA markers for diagnosis of tuberculosisTuberculosis, 2019
- MicroRNA hsa-miR-29a-3p is a plasma biomarker for the differential diagnosis and monitoring of tuberculosisTuberculosis, 2019
- Decreased neutrophil–associated miRNA and increased B-cell associated miRNA expression during tuberculosisGene, 2018
- Correlation and variable importance in random forestsStatistics and Computing, 2016
- Altered microRNA expression levels in mononuclear cells of patients with pulmonary and pleural tuberculosis and their relation with components of the immune responseMolecular Immunology, 2013